(firstQuint)Single and Multiple Dose Escalation Study of VX-509 in Healthy Subjects.

 Part A of the study will evaluate the safety and tolerability, PK, and PD of single ascending doses of VX-509.

 Part B will evaluate the safety and tolerability, PK, and PD of multiple ascending doses of VX-509 administered for 14 days.

 A total of 72 subjects will be enrolled: 36 subjects in Part A and 36 subjects in Part B.

.

 Single and Multiple Dose Escalation Study of VX-509 in Healthy Subjects@highlight

Study to evaluate the safety and tolerability of single ascending doses and multiple ascending doses of VX-509 administered to healthy male and female subjects